Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001615774-17-003120
Filing Date
2017-06-13
Accepted
2017-06-13 10:16:41
Documents
11

Document Format Files

Seq Description Document Type Size
1 424B4 s106528_424b4.htm 424B4 2633054
2 GRAPHIC logo_424b4.jpg GRAPHIC 7712
3 GRAPHIC pg8img1_424b4.jpg GRAPHIC 122283
4 GRAPHIC pg64img1_424b4.jpg GRAPHIC 122283
5 GRAPHIC pg67img1_424b4.jpg GRAPHIC 135537
6 GRAPHIC pg68img1_424b4.jpg GRAPHIC 67786
7 GRAPHIC pg72img1_424b4.jpg GRAPHIC 192345
8 GRAPHIC pg72img2_424b4.jpg GRAPHIC 41039
9 GRAPHIC pg72img3_424b4.jpg GRAPHIC 39412
10 GRAPHIC pg73img1_424b4.jpg GRAPHIC 38716
11 GRAPHIC pg77img1_424b4.jpg GRAPHIC 81822
  Complete submission text file 0001615774-17-003120.txt   3804354
Mailing Address PO BOX 8694 ARMADALE, VICTORIA C3 3143
Business Address PO BOX 8694 ARMADALE, VICTORIA C3 3143 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B4 | Act: 33 | File No.: 333-215204 | Film No.: 17908097
SIC: 2834 Pharmaceutical Preparations